Peripheral blood biomarkers in idiopathic pulmonary fibrosis

Translational Research

Volumn 159, Issue 4, 2012, Pages 218-227

  Vij, Rekha ^a   Noth, Imre ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; BETA CHEMOKINE; BIOLOGICAL MARKER; BRAIN NATRIURETIC PEPTIDE; CC CHEMOKINE LIGAND 18; CHEMOKINE; CHITINASE; GLYCOPROTEIN; INTERSTITIAL COLLAGENASE; KREBS VON DEN LUNGEN 6 ANTIGEN; MATRILYSIN; MUCIN; OSTEOPONTIN; SURFACTANT PROTEIN A; SURFACTANT PROTEIN D; TRANSCRIPTION FACTOR RUNX2; UNCLASSIFIED DRUG; VASCULOTROPIN;

ACUTE HEART FAILURE; BLOOD; CD4 CD8 RATIO; CELL ASSAY; CELL COUNT; CLINICAL TRIAL (TOPIC); COMPUTER ASSISTED TOMOGRAPHY; DISEASE ACTIVITY; DISEASE COURSE; HEART VENTRICLE FUNCTION; HUMAN; HYPOALBUMINEMIA; IDIOPATHIC DISEASE; IMMUNOHISTOCHEMISTRY; INTERSTITIAL LUNG DISEASE; INTERSTITIAL PNEUMONIA; LUNG BIOPSY; LUNG FIBROSIS; LUNG FUNCTION TEST; LUNG LAVAGE; LUNG SARCOIDOSIS; LUNG TRANSPLANTATION; MONITORING; MORTALITY; MULTICENTER STUDY; MULTICENTER STUDY (TOPIC); MYOFIBROBLAST; NONHUMAN; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PULMONARY HYPERTENSION; REGULATORY T LYMPHOCYTE; REVIEW; SENSITIVITY AND SPECIFICITY; T LYMPHOCYTE; TRANSTHORACIC ECHOCARDIOGRAPHY;

EID: 84858427847     PISSN: 19315244     EISSN: 18781810     Source Type: Journal    
DOI: 10.1016/j.trsl.2012.01.012     Document Type: Review

References (83)

1. Bureau USC. 2010 Census Briefs. Available at: http://2010.census.gov/ 2010census/data/. Accessed November 23, 2011.
2. E.R. Fernandez Perez, C.E. Daniels, and D.R. Schroeder Incidence, prevalence, and clinical course of idiopathic pulmonary fibrosis: a population-based study Chest 137 2010 129 137
3. D.S. Kim, H.R. Collard, and T.E. King Jr. Classification and natural history of the idiopathic interstitial pneumonias Proc Am Thorac Soc 3 2006 285 292
4. G. Raghu, H.R. Collard, and J.J. Egan An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management Am J Respir Crit Care Med 183 2011 788 824
5. A.L. Katzenstein, and J.L. Myers Idiopathic pulmonary fibrosis: clinical relevance of pathologic classification Am J Respir Crit Care Med 157 4 Pt 1 1998 1301 1315
6. H.N. Kim, and J.L. Januzzi Jr. Natriuretic peptide testing in heart failure Circulation 123 2011 2015 2019
7. G.C. Fonarow, W.F. Peacock, C.O. Phillips, M.M. Givertz, and M. Lopatin Admission B-type natriuretic peptide levels and in-hospital mortality in acute decompensated heart failure J Am Coll Cardiol 49 2007 1943 1950
8. H.H. Leuchte, M. Holzapfel, and R.A. Baumgartner Clinical significance of brain natriuretic peptide in primary pulmonary hypertension J Am Coll Cardiol 43 2004 764 770
9. J.W. Song, J.K. Song, and D.S. Kim Echocardiography and brain natriuretic peptide as prognostic indicators in idiopathic pulmonary fibrosis Respir Med 103 2009 180 186
10. H.H. Leuchte, R.A. Baumgartner, and M.E. Nounou Brain natriuretic peptide is a prognostic parameter in chronic lung disease Am J Respir Crit Care Med 173 2006 744 750
11. T.J. Corte, S.J. Wort, and M.A. Gatzoulis Elevated brain natriuretic peptide predicts mortality in interstitial lung disease Eur Respir J 36 2010 819 825
12. T. Boonpipattanapong, and S. Chewatanakornkul Preoperative carcinoembryonic antigen and albumin in predicting survival in patients with colon and rectal carcinomas Journal of Clin gastroenterology 40 2006 592 595
13. D. Gupta, and C.G. Lis Pretreatment serum albumin as a predictor of cancer survival: a systematic review of the epidemiological literature Nutrition J 9 2010 69
14. R.M. Bologa, D.M. Levine, and T.S. Parker Interleukin-6 predicts hypoalbuminemia, hypocholesterolemia, and mortality in hemodialysis patients Am J Kidney Diseases: the official journal of the National Kidney Foundation 32 1998 107 114
15. V. Menon, T. Greene, and X. Wang C-reactive protein and albumin as predictors of all-cause and cardiovascular mortality in chronic kidney disease Kidney international 68 2005 766 772
16. D.A. Zisman, S.M. Kawut, and D.J. Lederer Serum albumin concentration and waiting list mortality in idiopathic interstitial pneumonia Chest 135 2009 929 935
17. S. Bandoh, J. Fujita, and Y. Ohtsuki Sequential changes of KL-6 in sera of patients with interstitial pneumonia associated with polymyositis/ dermatomyositis Ann Rheum Dis 59 2000 257 262
18. Y. Hirasawa, N. Kohno, A. Yokoyama, Y. Inoue, M. Abe, and K. Hiwada KL-6, a human MUC1 mucin, is chemotactic for human fibroblasts Am J Respir Cell Mol Biol 17 1997 501 507
19. S. Ohshimo, A. Yokoyama, N. Hattori, N. Ishikawa, Y. Hirasawa, and N. Kohno KL-6, a human MUC1 mucin, promotes proliferation and survival of lung fibroblasts Biochem Biophys Res Commun 338 2005 1845 1852
20. H. Ishii, H. Mukae, and J. Kadota High serum concentrations of surfactant protein A in usual interstitial pneumonia compared with nonspecific interstitial pneumonia Thorax 58 2003 52 57
21. H. Ohnishi, A. Yokoyama, and K. Kondo Comparative study of KL-6, surfactant protein-A, surfactant protein-D, and monocyte chemoattractant protein-1 as serum markers for interstitial lung diseases Am J Respir Crit Care Med 165 2002 378 381
22. N. Kohno, Y. Awaya, and T. Oyama KL-6, a mucin-like glycoprotein, in bronchoalveolar lavage fluid from patients with interstitial lung disease Am Rev Respir Dis 148 1993 637 642
23. H. Satoh, K. Kurishima, H. Ishikawa, and M. Ohtsuka Increased levels of KL-6 and subsequent mortality in patients with interstitial lung diseases J Intern Med 260 2006 429 434
24. A. Yokoyama, N. Kohno, and H. Hamada Circulating KL-6 predicts the outcome of rapidly progressive idiopathic pulmonary fibrosis Am J Respir Crit Care Med 158 5 Pt 1 1998 1680 1684
25. J. Goerke Pulmonary surfactant: functions and molecular composition Biochimica Biophysica Acta 1408 1998 79 89
26. U. Kishore, T.J. Greenhough, and P. Waters Surfactant proteins SP-A and SP-D: structure, function and receptors Mol Immunol 43 2006 1293 1315
27. K.E. Greene, T.E. King Jr., and Y. Kuroki Serum surfactant proteins-A and -D as biomarkers in idiopathic pulmonary fibrosis Eur Respir J 19 2002 439 446
28. N. Nagata, Y. Kitasato, and K. Wakamatsu Prognostic value of immunohistochemical surfactant protein A expression in regenerative/hyperplastic alveolar epithelial cells in idiopathic interstitial pneumonias Diagn Pathol 6 2011 25
29. B.W. Kinder, K.K. Brown, and F.X. McCormack Serum surfactant protein-A is a strong predictor of early mortality in idiopathic pulmonary fibrosis Chest 135 2009 1557 1563
30. H. Takahashi, T. Fujishima, and H. Koba Serum surfactant proteins A and D as prognostic factors in idiopathic pulmonary fibrosis and their relationship to disease extent Am J Respir Crit Care Med 162 3 Pt 1 2000 1109 1114
31. L.M. Nogee, A.E. Dunbar III, S.E. Wert, F. Askin, A. Hamvas, and J.A. Whitsett A mutation in the surfactant protein C gene associated with familial interstitial lung disease N Engl J Med 344 2001 573 579
32. R.S. Amin, S.E. Wert, and R.P. Baughman Surfactant protein deficiency in familial interstitial lung disease J Pediatr 139 2001 85 92
33. A.Q. Thomas, K. Lane, and J. Phillips III Heterozygosity for a surfactant protein C gene mutation associated with usual interstitial pneumonitis and cellular nonspecific interstitial pneumonitis in one kindred Am J Respir Crit Care Med 165 2002 1322 1328
34. W.E. Lawson, S.W. Grant, and V. Ambrosini Genetic mutations in surfactant protein C are a rare cause of sporadic cases of IPF Thorax 59 2004 977 980
35. S. Oikonomidi, K. Kostikas, I. Tsilioni, K. Tanou, K.I. Gourgoulianis, and T.S. Kiropoulos Matrix metalloproteinases in respiratory diseases: from pathogenesis to potential clinical implications Curr Med Chem 16 2009 1214 1228
36. W. Sauter, A. Rosenberger, and L. Beckmann Matrix metalloproteinase 1 (MMP1) is associated with early-onset lung cancer Cancer Epidemiol Biomarkers Prev 17 2008 1127 1135
37. F. Zuo, N. Kaminski, and E. Eugui Gene expression analysis reveals matrilysin as a key regulator of pulmonary fibrosis in mice and humans Proc Nat Acad Sci USA 99 2002 6292 6297
38. S. Fujishima, T. Shiomi, and S. Yamashita Production and activation of matrix metalloproteinase 7 (matrilysin 1) in the lungs of patients with idiopathic pulmonary fibrosis Arch Path Laboratory Med 134 2010 1136 1142
39. K. Vuorinen, M. Myllarniemi, and L. Lammi Elevated matrilysin levels in bronchoalveolar lavage fluid do not distinguish idiopathic pulmonary fibrosis from other interstitial lung diseases APMIS 115 2007 969 975
40. J.W. Huh, D.S. Kim, and Y.M. Oh Is metalloproteinase-7 specific for idiopathic pulmonary fibrosis? Chest 133 2008 1101 1106
41. I.O. Rosas, T.J. Richards, and K. Konishi MMP1 and MMP7 as potential peripheral blood biomarkers in idiopathic pulmonary fibrosis PLoS Med 5 2008 e93
42. T.J. Richards, N. Kaminski, and F. Baribaud Peripheral blood proteins predict mortality in idiopathic pulmonary fibrosis Am J Respir Crit Care Med 185 1 2012 67 76
43. I.G. Luzina, N. Tsymbalyuk, J. Choi, J.D. Hasday, and S.P. Atamas CCL18-stimulated up-regulation of collagen production in lung fibroblasts requires Sp1 signaling and basal Smad3 activity J Cell Physiol 206 2006 221 228
44. A. Prasse, D.V. Pechkovsky, and G.B. Toews A vicious circle of alveolar macrophages and fibroblasts perpetuates pulmonary fibrosis via CCL18 Am J Respir Crit Care Med 173 2006 781 792
45. M. Kodera, M. Hasegawa, K. Komura, K. Yanaba, K. Takehara, and S. Sato Serum pulmonary and activation-regulated chemokine/CCL18 levels in patients with systemic sclerosis: a sensitive indicator of active pulmonary fibrosis Arthritis Rheumatism 52 2005 2889 2896
46. A. Prasse, D.V. Pechkovsky, and G.B. Toews CCL18 as an indicator of pulmonary fibrotic activity in idiopathic interstitial pneumonias and systemic sclerosis Arthritis Rheum 56 2007 1685 1693
47. A. Prasse, C. Probst, and E. Bargagli Serum CC-chemokine ligand 18 concentration predicts outcome in idiopathic pulmonary fibrosis Am J Respir Crit Care Med 179 2009 717 723
48. W.T. Monacci, M.J. Merrill, and E.H. Oldfield Expression of vascular permeability factor/vascular endothelial growth factor in normal rat tissues Am J Physiol 264 4 Pt 1 1993 C995 1002
49. M. Ando, E. Miyazaki, and T. Ito Significance of serum vascular endothelial growth factor level in patients with idiopathic pulmonary fibrosis Lung 188 2010 247 252
50. A. Tzouvelekis, S. Anevlavis, and D. Bouros Angiogenesis in interstitial lung diseases: a pathogenetic hallmark or a bystander? Respir Res 7 2006 82
51. S. Koyama, E. Sato, M. Haniuda, H. Numanami, S. Nagai, and T. Izumi Decreased level of vascular endothelial growth factor in bronchoalveolar lavage fluid of normal smokers and patients with pulmonary fibrosis Am J Respir Crit Care Med 166 2002 382 385
52. K.C. Meyer, A. Cardoni, and Z.Z. Xiang Vascular endothelial growth factor in bronchoalveolar lavage from normal subjects and patients with diffuse parenchymal lung disease J Lab Clin Med 135 2000 332 338
53. J.S. Johansen, P. Christoffersen, and S. Moller Serum YKL-40 is increased in patients with hepatic fibrosis J Hepatol 32 2000 911 920
54. A. Kruit, J.C. Grutters, H.J. Ruven, C.C. van Moorsel, and J.M. van den Bosch A CHI3L1 gene polymorphism is associated with serum levels of YKL-40, a novel sarcoidosis marker Respir Med 101 2007 1563 1571
55. S. Letuve, A. Kozhich, and N. Arouche YKL-40 is elevated in patients with chronic obstructive pulmonary disease and activates alveolar macrophages J Immunol 181 2008 5167 5173
56. G.L. Chupp, C.G. Lee, and N. Jarjour A chitinase-like protein in the lung and circulation of patients with severe asthma N Engl J Med 357 2007 2016 2027
57. C. Ober, and G.L. Chupp The chitinase and chitinase-like proteins: a review of genetic and functional studies in asthma and immune-mediated diseases Curr Opin Allergy Clin Immunol 9 2009 401 408
58. K. Furuhashi, T. Suda, and Y. Nakamura Increased expression of YKL-40, a chitinase-like protein, in serum and lung of patients with idiopathic pulmonary fibrosis Respir Med 104 2010 1204 1210
59. N.M. Korthagen, C.H. van Moorsel, and N.P. Barlo Serum and BALF YKL-40 levels are predictors of survival in idiopathic pulmonary fibrosis Respir Med 105 2011 106 113
60. D.T. Denhardt, M. Noda, A.W. O'Regan, D. Pavlin, and J.S. Berman Osteopontin as a means to cope with environmental insults: regulation of inflammation, tissue remodeling, and cell survival J Clin Invest 107 2001 1055 1061
61. A. O'Regan, and J.S. Berman Osteopontin: a key cytokine in cell-mediated and granulomatous inflammation Int J Exp Pathol 81 2000 373 390
62. F. Takahashi, K. Takahashi, and T. Okazaki Role of osteopontin in the pathogenesis of bleomycin-induced pulmonary fibrosis Am J Respir Cell Mol Biol 24 2001 264 271
63. A. Pardo, K. Gibson, and J. Cisneros Up-regulation and profibrotic role of osteopontin in human idiopathic pulmonary fibrosis PLoS Med 2 2005 e251
64. J. Kadota, S. Mizunoe, and K. Mito High plasma concentrations of osteopontin in patients with interstitial pneumonia Respir Med 99 2005 111 117
65. M. Okamoto, T. Hoshino, and Y. Kitasato Periostin, a matrix protein, is a novel biomarker for idiopathic interstitial pneumonias Eur Respir J 37 2011 1119 1127
66. S.S. Sidhu, S. Yuan, and A.L. Innes Roles of epithelial cell-derived periostin in TGF-beta activation, collagen production, and collagen gel elasticity in asthma Proc Nat Acad Sci 107 2010 14170 14175
67. A. Saito, H. Okazaki, I. Sugawara, K. Yamamoto, and H. Takizawa Potential action of IL-4 and IL-13 as fibrogenic factors on lung fibroblasts in vitro Int Arch Allergy Immunol 132 2003 168 176
68. J.L. Ingram, A.B. Rice, K. Geisenhoffer, D.K. Madtes, and J.C. Bonner IL-13 and IL-1beta promote lung fibroblast growth through coordinated up-regulation of PDGF-AA and PDGF-Ralpha FASEB J 18 2004 1132 1134
69. A. Oriente, N.S. Fedarko, S.E. Pacocha, S.K. Huang, L.M. Lichtenstein, and D.M. Essayan Interleukin-13 modulates collagen homeostasis in human skin and keloid fibroblasts J Pharmacol Exp Ther 292 2000 988 994
70. L.A. Murray, R.L. Argentieri, and F.X. Farrell Hyper-responsiveness of IPF/UIP fibroblasts: interplay between TGFbeta1, IL-13, and CCL2 Int J Biochem Cell Biol 40 2008 2174 2182
71. J. Corren, R.F. Lemanske, and N.A. Hanania Lebrikizumab treatment in adults with asthma N Engl J Med 365 2011 1088 1098
72. A. Bellini, and S. Mattoli The role of the fibrocyte, a bone marrow-derived mesenchymal progenitor, in reactive and reparative fibroses Lab Invest 87 2007 858 870
73. B.B. Moore, J.E. Kolodsick, and V.J. Thannickal CCR2-mediated recruitment of fibrocytes to the alveolar space after fibrotic injury Am J Pathol 166 2005 675 684
74. A. Andersson-Sjöland, C.G. de Alba, and K. Nihlberg Fibrocytes are a potential source of lung fibroblasts in idiopathic pulmonary fibrosis Int J Biochem Cell Biol 40 2008 2129 2140
75. A. Moeller, S.E. Gilpin, and K. Ask Circulating fibrocytes are an indicator of poor prognosis in idiopathic pulmonary fibrosis Am J Respir Crit Care Med 179 2009 588 594
76. J.D. Christie, L.B. Edwards, and A.Y. Kucheryavaya The Registry of the International Society for Heart and Lung Transplantation: twenty-seventh official adult lung and heart-lung transplant report-2010 J Heart Lung Transplantation 29 2010 1104 1118
77. J.B. Orens, T.H. Shearon, R.S. Freudenberger, J.V. Conte, S.M. Bhorade, and A. Ardehali Thoracic organ transplantation in the United States, 1995-2004 Am J Transplantation 6 5 Pt 2 2006 1188 1197
78. A.T. Borchers, C. Chang, C.L. Keen, and M.E. Gershwin Idiopathic pulmonary fibrosis-an epidemiological and pathological review Clin Rev Allergy Immunol 40 2011 117 134
79. E.R. Parra, R.A. Kairalla, C.R. Ribeiro de Carvalho, E. Eher, and V.L. Capelozzi Inflammatory cell phenotyping of the pulmonary interstitium in idiopathic interstitial pneumonia Respiration 74 2007 159 169
80. Z. Daniil, P. Kitsanta, and G. Kapotsis CD8+ T lymphocytes in lung tissue from patients with idiopathic pulmonary fibrosis Respir Res 6 2005 81
81. I.O. Rosas, P. Ren, and N.A. Avila Early interstitial lung disease in familial pulmonary fibrosis Am J Respir Crit Care Med 176 2007 698 705
82. S.R. Gilani, L.J. Vuga, and K.O. Lindell CD28 down-regulation on circulating CD4 T-cells is associated with poor prognoses of patients with idiopathic pulmonary fibrosis PLoS One 5 2010 e8959
83. I. Kotsianidis, E. Nakou, and I. Bouchliou Global impairment of CD4+CD25+FOXP3+ regulatory T cells in idiopathic pulmonary fibrosis Am J Respir Crit Care Med 179 2009 1121